Researchers structurally analyzed adenine nucleotide control and neurodegenerative diseases in ClC-3 exchangers.
Pharma enters ‘age of uncertainty’ amid challenges from IRA, FTC and patent cliffs
It’s been a demanding year for the pharma industry. There’s a more aggressive FTC, a changing FDA, tough market conditions, and a legal fight over